Lipolanthionine peptides act as inhibitors of TLR2-mediated IL-8 secretion.: Synthesis and structure-activity relationships
Lipolanthionine peptides act as inhibitors of TLR2-mediated IL-8 secretion.: Synthesis and structure-activity relationships
复制标题
DOI:
10.1021/jm050585d
复制
发表时间:
2006-03-09
影响因子:
7.3
通讯作者:
Jung, G
中科院分区:
文献类型:
--
作者:
Seyberth, T;Voss, S;Jung, G
Lipoproteins from Gram-positive and -negative bacteria, mycoplasma, and shorter synthetic lipopeptide analogues activate cells of the innate immune system via the Toll-like receptor TLR2/TLR1 or TLR2/TLR6 heterodimers. For this reason, these compounds constitute highly active adjuvants for vaccines either admixed or covalently linked. The lanthionine scaffold has structural similarity with the S-(2,3-dihydroxypropyl)cysteine core structure of the lipopeptides. Therefore, lanthionine-based lipopeptide amides were synthesized and probed for activity as potential TLR2 agonists or antagonists. A collection of analytically defined lipolanthionine peptide amides exhibited an inhibitory effect of the TLR2-mediated IL-8 secretion when applied in high molar excess to the agonistic synthetic lipopeptide Pam(3)Cys-Ser-(LyS)(4)-OH. Structure-activity relationships revealed the influence of the chirality of the two alpha-carbon atoms, the chain lengths of the attached fatty acids and fatty amines, and the oxidation level of the sulfur atom on the inhibitory activity of the lipolanthionine peptide amides.